Abstract:Muscular dystrophy (MD) is a group of inherited conditions causing progressive muscle weakness and wasting, for which no widely implementable treatment currently exists, although resistance training (Bostock et al., 2019, Frontiers in Neurology, 10) and corticosteroid treatment (Angelini, 2007, Muscle & Nerve, 36, 424-435), have been shown to improve health-related quality of life (HQoL). Compared to physical activity, dietary manipulation may be more modifiable to improve dystrophic populations HQoL as disease outcomes often restrict physical capabilities. Data exploring the relationship between diet, disease and HQoL outcomes in adults with MD is insufficient. This study evaluated the habitual dietary intake of a sex-inclusive dystrophic population, to identify possible links between dietary intake, HQoL, and physical function. Participants included 5 women (age 65 ± 14 yrs, BMI 23.2 ± 2.7 kg/m2) and 10 men (age 55 ± 19 yrs, 31.6 ± 7.9 kg/m2) with different MDs (varied distribution and severity of muscle weakness). Participants' dietary intake data was collected using 3-day food records: analysed using Nutritics. Dominant hand maximal grip strength was measured using a hand-held dynamometer; upper extremity function and pain were assessed using the upper extremity functional index-15 and visual analogue scale, respectively. QoL was assessed through three tools: SF-36V2, Barthel Index and EQ5D, previously used in dystrophic populations. We observed that 50% of men and 20% of women did not meet the recommended daily intake (RDI) for protein (0.8 g·kg−1), however women (1.13 ± 0.26 g·kg−1) had increased protein intake compared to men (0.82 ± 0.27 g·kg−1, p < 0.05). Of all participants 40% had a daily fat intake exceeding the RDI, with women having significantly higher relative average fat intakes (women = 1.03 ± 0.36 g·kg−1, men = 0.68 ± 0.29 g·kg−1, p < 0.05). RDI for calcium was met by 46% participants (1000 mg) whilst all failed to meet the vitamin D RDI (10 μg). Positive correlations between age and protein intake as a percentage of RDI (r2 = 0.82), protein (r2 = 0.82), carbohydrate intake (r2 = 0.55) relative to body mass, vitamin D intake (r2 = 0.54), and total caloric intake (r2 = 0.59, all p< 0.05) were observed. No other significant associations between dietary habits, physical function or HQoL outcomes were apparent. Despite these findings being observed in a small population it is apparent that many adults with muscular dystrophy may fail to meet RDI for protein, vitamin D, and calcium. This places this population at risk for nutritional deficiencies, incurring negative impacts on the musculoskeletal system. Further study of nutritional status in a larger population sample is needed to confirm these findings.

Energy expenditure, body composition, and prevalence of metabolic disorders in patients with Duchenne muscular dystrophy

Assessing change in body composition in children with Duchenne muscular dystrophy: anthropometry and bioelectrical impedance analysis versus dual-energy X-ray absorptiometry

Clinical assessment underestimates fat mass and overestimates resting energy expenditure in children with neuromuscular diseases

Nutritional Issues among Children with Duchenne Muscular Dystrophy-Incidence of Deficiency and Excess Body Mass

Is Exercise-Induced Fatigue a Problem in Children with Duchenne Muscular Dystrophy?

Reductions in functional muscle mass and ability to ambulate in Duchenne muscular dystrophy from ages 4 to 24 years

Estimating body composition in children with Duchenne muscular dystrophy: comparison of bioelectrical impedance analysis and skinfold-thickness measurement

Comparison of energy expenditure of individuals with Duchenne Muscular Dystrophy in the sitting posture on the ground and in water

Hepatic Steatosis Assessment as a New Strategy for the Metabolic and Nutritional Management of Duchenne Muscular Dystrophy

Appendicular lean mass index and motor function in ambulatory patients with Duchenne muscular dystrophy

1022 Sleep in Duchenne Muscular Dystrophy

Functional outcome measures in young, steroid-naïve boys with Duchenne muscular dystrophy

The metabolomic plasma profile of patients with Duchenne muscular dystrophy: providing new evidence for its pathogenesis

Dietary intakes and nutritional status in adults with Muscular Dystrophy

Assessing Physical Activity Using Accelerometers in Youth with Duchenne Muscular Dystrophy

Is endocrine surveillance important in the care of Duchenne Muscular Dystrophy? Results from a national survey to patients and families on endocrine complications

How is Physical Activity Measured in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy?

Nutritional, Lipid Metabolic and Body Composition Features of Children with Spinal Muscular Atrophy

Predictors of Loss of Ambulation in Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis

Validity of bioelectrical impedance to estimate fat-free mass in boys with Duchenne muscular dystrophy

Intermittent versus daily regimen of prednisolone in ambulatory boys with Duchenne muscular dystrophy: A randomized, open-label trial